Abstract:Accumulating evidence indicates that oncogenic viral protein plays a crucial role in activating aerobic glycolysis during tumorigenesis, but the underlying mechanisms are largely undefined. Epstein-Barr virus ( EBV)-encoded latent membrane protein 1 ( LMP1) is a transmembrane protein with potent cell signaling properties and has tumorigenic transformation property. Activation of NF-kappa B is a major signaling pathway mediating many downstream transformation properties of LMP1. Here we report that activation of mTORC1 by LMP1 is a key modulator for activation of NF-kappa B signaling to mediate aerobic glycolysis. NF-kappa B activation is involved in the LMP1-induced upregulation of glucose transporter 1 ( Glut-1) transcription and growth of nasopharyngeal carcinoma ( NPC) cells. Blocking the activity of mTORC1 signaling effectively suppressed LMP1-induced NF-kappa B activation and Glut-1 transcription. Interfering NF-kappa B signaling had no effect on mTORC1 activity but effectively altered Glut-1 transcription. Luciferase promoter assay of Glut-1 also confirmed that the Glut-1 gene is a direct target gene of NF-kappa B signaling. Furthermore, we demonstrated that C-terminal activating region 2 ( CTAR2) of LMP1 is the key domain involved in mTORC1 activation, mainly through IKK beta-mediated phosphorylation of TSC2 at Ser(939). Depletion of Glut-1 effectively led to suppression of aerobic glycolysis, inhibition of cell proliferation, colony formation, and attenuation of tumorigenic growth property of LMP1- expressing nasopharyngeal epithelial ( NPE) cells. These findings suggest that targeting the signaling axis of mTORC1/NF-kappa B/ Glut-1 represents a novel therapeutic target against NPC. IMPORTANCE Aerobic glycolysis is one of the hallmarks of cancer, including NPC. Recent studies suggest a role for LMP1 in mediating aerobic glycolysis. LMP1 expression is common in NPC. The delineation of essential signaling pathways induced by LMP1 in aerobic glycolysis contributes to the understanding of NPC pathogenesis. This study provides evidence that LMP1 upregulates Glut-1 transcription to control aerobic glycolysis and tumorigenic growth of NPC cells through mTORC1/NF-kappa B signaling. Our results reveal novel therapeutic targets against the mTORC1/NF-kappa B/Glut-1 signaling axis in the treatment of EBV-infected NPC.

Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties

EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties

EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Formation

Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial-Mesenchymal Transition and Increases the Number of Side Population Stem-Like Cancer Cells in Nasopharyngeal Carcinoma.

EBV Latent Membrane Proteins Promote Hybrid Epithelial-Mesenchymal and Extreme Mesenchymal States of Nasopharyngeal Carcinoma Cells for Tumorigenicity.

Epstein-Barr Virus Encoded Latent Membrane Protein 1 Regulates Mtor Signaling Pathway Genes Which Predict Poor Prognosis of Nasopharyngeal Carcinoma

EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Promotes Extracellular Vesicle Secretion Through Syndecan-2 and Synaptotagmin-Like-4 in Nasopharyngeal Carcinoma Cells

Role of Epstein-Barr Virus Encoded Latent Membrane Protein 1 in the Carcinogenesis of Nasopharyngeal Carcinoma.

Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.

Epstein-Barr Virus Encoded LMP1 Regulates Cyclin D1 Promoter Activity by Nuclear EGFR and STAT3 in CNE1 Cells

Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103

Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma

Epstein–Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-κB p65 in human nasopharyngeal carcinoma cells

Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.

Abstract 3360: EB-virus Latent Membrane Protein 1 Potentiates the Stemness of Nasopharyngealcarcinoma Via Preferential Activation of PI3K/AKT Pathway by a Positive Feedback Loop

The Epstein-Barr Virus Encoded Latent Membrane Protein 1 Promotes Nuclear Factor-kappa B Activity in a Nasopharyngeal Carcinoma Cell Line

Cancer Stem-Like Cell Characteristics Induced by EB Virus-Encoded LMP1 Contribute to Radioresistance in Nasopharyngeal Carcinoma by Suppressing the P53-Mediated Apoptosis Pathway

Regulation of Survivin and CDK4 by Epstein-Barr Virus Encoded Latent Membrane Protein 1 in Nasopharyngeal Carcinoma Cell Lines

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways

Extracellular Vesicle Packaged LMP1-activated Fibroblasts Promote Tumor Progression Via Autophagy and Stroma-Tumor Metabolism Coupling.